journal article·2025-06Open access

High Fat Low Carbohydrate Diet Is Linked to CNS Autoimmunity Protection

Duan Ni, Jian Tan, Julen Reyes, Alistair M Senior, Caitlin Andrews, Jemma Taitz, Camille Potier‐Villette, Claire Wishart, Alanna Spiteri, Laura Piccio, Nicholas Jonathan Cole King, Romain Barrès, David Raubenheimer, Stephen James Simpson, Ralph Nanan, Laurence Macia

Advanced Science· Volume 12· Issue 22

Abstract

Abstract Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system (CNS) believed to be driven by autoimmune mechanisms. Genetic and environmental factors are implicated in MS development, and among the latter, diets and nutrients are emerging as potential critical contributors. However, a comprehensive understanding of their impacts and the underlying mechanisms involved is lacking. Harnessing state‐of‐the‐art nutritional geometry analytical methods, it is first revealed that globally, increased carbohydrate supply is associated with increased MS disease burden, while fat supply has an opposite effect. Furthermore, in a MS mouse model, experimental autoimmune encephalomyelitis (EAE), it is found that an isocaloric diet high in carbohydrate aggravated EAE, while a diet enriched in fat (HF) is fully protective. This is reflected by reduced neuroinflammation and skewing toward anti‐inflammatory phenotypes. The protective effects from the HF diet are multifaceted. Metabolically, HF increased lipid storage in immune cells, correlating with their increased anti‐inflammatory IL‐10 production. Transcriptionally and epigenetically, HF feeding preprogrammed naïve T cells toward a less activated but more tolerogenic phenotype. It is showcased that manipulating diets is a potentially efficient and cost‐effective approach to prevent and/or ameliorate EAE. This exhibits translational potentials for prevention/intervention of MS and possibly other autoimmune diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune Cell Function and Interaction · Cytokine Signaling Pathways and Interactions · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Charles Perkins Centre The University of Sydney D17 Charles Perkins Centre Sydney NSW 2006 Australia

School of Medical Sciences Faculty of Medicine and Health The University of Sydney Sydney NSW 2006 Australia

Sydney Medical School Nepean The University of Sydney Sydney NSW 2747 Australia

Nepean Hospital Nepean Blue Mountains Local Health District Sydney NSW 2747 Australia

School of Life and Environmental Sciences The University of Sydney Sydney NSW 2006 Australia

Sydney Precision Data Science Centre The University of Sydney Sydney NSW 2006 Australia

Viral immunopathology Laboratory Infection Immunity and Inflammation Research Theme School of Medical Sciences Faculty of Medicine and Health The University of Sydney Sydney NSW 2006 Australia

Brain and Mind Centre The University of Sydney Sydney NSW 2006 Australia

The University of Sydney Institute for Infectious Diseases The University of Sydney Sydney NSW 2006 Australia

Sydney Nano The University of Sydney Sydney NSW 2006 Australia

Novo Nordisk Foundation Center for Basic Metabolic Research University of Copenhagen Copenhagen 2200 Denmark

Institut de Pharmacologie Moléculaire et Cellulaire Université Côte d'Azur & Centre National pour la Recherche Scientifique (CNRS) Valbonne 06560 France

Funding

Novo Nordisk Foundation Center for Basic Metabolic Research · Australian Research Council

References (99)

Show source-provided references
1. 10.1016/S1474-4422(14)70267-410.1016/S1474-4422(14)70267-4 ↗
2. 10.1101/cshperspect.a02894410.1101/cshperspect.a028944 ↗
3. 10.1136/jnnp-2024-33406210.1136/jnnp-2024-334062 ↗
4. 10.1038/s41572-018-0041-410.1038/s41572-018-0041-4 ↗
5. 10.1097/00000441-195022040-0001110.1097/00000441-195022040-00011 ↗
6. 10.1111/nyas.1358310.1111/nyas.13583 ↗
7. 10.1212/WNL.000000000020156510.1212/WNL.0000000000201565 ↗
8. 10.1007/s11481-013-9502-410.1007/s11481-013-9502-4 ↗
9. 10.1016/j.immuni.2015.09.00710.1016/j.immuni.2015.09.007 ↗
10. 10.1016/j.celrep.2016.05.04710.1016/j.celrep.2016.05.047 ↗
11. 10.1172/jci.insight.14415610.1172/jci.insight.144156 ↗
12. 10.1016/j.celrep.2022.11132810.1016/j.celrep.2022.111328 ↗
13. 10.1136/jnnp-2017-31593610.1136/jnnp-2017-315936 ↗
14. 10.1080/1028415X.2022.203424110.1080/1028415X.2022.2034241 ↗
15. 10.1016/j.msard.2019.10140310.1016/j.msard.2019.101403 ↗
16. 10.1016/j.isci.2021.10283510.1016/j.isci.2021.102835 ↗
17. 10.1038/s42003-020-1027-910.1038/s42003-020-1027-9 ↗
18. 10.1016/j.cmet.2022.02.01510.1016/j.cmet.2022.02.015 ↗
19. 10.1084/jem.2011027810.1084/jem.20110278 ↗
20. 10.4049/jimmunol.100361310.4049/jimmunol.1003613 ↗
21. 10.1016/j.celrep.2016.05.00910.1016/j.celrep.2016.05.009 ↗
22. 10.1371/journal.pone.003547610.1371/journal.pone.0035476 ↗
23. 10.3389/fneur.2023.111395410.3389/fneur.2023.1113954 ↗
24. 10.1016/j.celrep.2024.11489110.1016/j.celrep.2024.114891 ↗
25. 10.1002/mnfr.20230060210.1002/mnfr.202300602 ↗
26. 10.1039/D3FO00122A10.1039/D3FO00122A ↗
27. 10.1186/s13075-022-02802-010.1186/s13075-022-02802-0 ↗
28. 10.1016/j.ebiom.2021.10379810.1016/j.ebiom.2021.103798 ↗
29. 10.1172/JCI12401210.1172/JCI124012 ↗
30. 10.1371/journal.pone.009209510.1371/journal.pone.0092095 ↗
31. 10.3389/fimmu.2019.0186010.3389/fimmu.2019.01860 ↗
32. 10.1093/lifemeta/loac03810.1093/lifemeta/loac038 ↗
33. 10.1016/j.it.2014.12.00510.1016/j.it.2014.12.005 ↗
34. 10.3390/nu1303082310.3390/nu13030823 ↗
35. 10.3390/nu1406115010.3390/nu14061150 ↗
36. 10.1111/all.1606710.1111/all.16067 ↗
37. 10.1186/s12915-022-01395-z10.1186/s12915-022-01395-z ↗
38. 10.1073/pnas.201505811710.1073/pnas.2015058117 ↗
39. 10.1016/j.cmet.2014.02.00910.1016/j.cmet.2014.02.009 ↗
40. 10.1146/annurev-animal-111523-10232710.1146/annurev-animal-111523-102327 ↗
41. 10.1002/bies.20240007110.1002/bies.202400071 ↗
42. 10.1038/s41467-022-31761-y10.1038/s41467-022-31761-y ↗
43. 10.1038/s41467-023-40039-w10.1038/s41467-023-40039-w ↗
44. 10.1016/j.celrep.2015.05.00710.1016/j.celrep.2015.05.007 ↗
45. 10.1016/j.cmet.2016.10.02110.1016/j.cmet.2016.10.021 ↗
46. 10.1016/j.cmet.2016.09.00110.1016/j.cmet.2016.09.001 ↗
47. 10.1016/j.jacl.2019.08.00310.1016/j.jacl.2019.08.003 ↗
48. 10.1002/eji.20235052110.1002/eji.202350521 ↗
49. 10.1016/j.cmet.2018.05.00610.1016/j.cmet.2018.05.006 ↗
50. 10.1093/jn/127.5.838S10.1093/jn/127.5.838S ↗
51. 10.1016/j.immuni.2004.09.01010.1016/j.immuni.2004.09.010 ↗
52. 10.1006/jaut.2001.052010.1006/jaut.2001.0520 ↗
53. 10.1002/eji.183027041610.1002/eji.1830270416 ↗
54. 10.1073/pnas.122289511010.1073/pnas.1222895110 ↗
55. 10.4049/jimmunol.090414510.4049/jimmunol.0904145 ↗
56. 10.1186/s12964-023-01447-z10.1186/s12964-023-01447-z ↗
57. 10.1016/j.jneuroim.2005.01.02010.1016/j.jneuroim.2005.01.020 ↗
58. 10.4049/jimmunol.180.11.737610.4049/jimmunol.180.11.7376 ↗
59. 10.1016/S1044-5323(02)00125-210.1016/S1044-5323(02)00125-2 ↗
60. 10.1523/JNEUROSCI.5804-08.200910.1523/JNEUROSCI.5804-08.2009 ↗
61. 10.1186/s12974-021-02214-y10.1186/s12974-021-02214-y ↗
62. 10.1212/NXI.000000000020004610.1212/NXI.0000000000200046 ↗
63. 10.1073/pnas.201468111810.1073/pnas.2014681118 ↗
64. 10.4049/jimmunol.170147710.4049/jimmunol.1701477 ↗
65. 10.4049/jimmunol.090380510.4049/jimmunol.0903805 ↗
66. 10.1111/j.1365-2567.2011.03483.x10.1111/j.1365-2567.2011.03483.x ↗
67. 10.1016/j.it.2023.01.00210.1016/j.it.2023.01.002 ↗
68. 10.1038/nri.2017.14610.1038/nri.2017.146 ↗
69. 10.1073/pnas.192132511710.1073/pnas.1921325117 ↗
70. 10.18637/jss.v072.c0210.18637/jss.v072.c02 ↗
71. 10.1136/jnnp-2022-32907410.1136/jnnp-2022-329074 ↗
72. 10.1093/advances/nmac06510.1093/advances/nmac065 ↗
73. 10.1189/jlb.020813310.1189/jlb.0208133 ↗
74. 10.1016/j.cmet.2018.08.00310.1016/j.cmet.2018.08.003 ↗
75. 10.1038/ni.346610.1038/ni.3466 ↗
76. 10.1038/nature1229710.1038/nature12297 ↗
77. 10.1073/pnas.201739411810.1073/pnas.2017394118 ↗
78. 10.1038/s41598-019-49868-610.1038/s41598-019-49868-6 ↗
79. 10.1371/journal.pone.023449310.1371/journal.pone.0234493 ↗
80. Bao R. · Am. J. Transl. Res. · 2016 · 8 · 2284
81. 10.1038/s41467-018-07735-410.1038/s41467-018-07735-4 ↗
82. 10.1002/eji.20083810510.1002/eji.200838105 ↗
83. 10.1182/blood-2009-05-21958410.1182/blood-2009-05-219584 ↗
84. 10.1097/MCO.0b013e328354715710.1097/MCO.0b013e3283547157 ↗
85. 10.1016/j.neuropharm.2015.08.00710.1016/j.neuropharm.2015.08.007 ↗
86. 10.1073/pnas.09264289910.1073/pnas.092642899 ↗
87. 10.1126/science.124116510.1126/science.1241165 ↗
88. 10.1016/j.celrep.2016.10.01210.1016/j.celrep.2016.10.012 ↗
89. Faugier J. · Nurs. Times · 1985 · 81 · 63
90. 10.1016/j.neuroscience.2017.09.05610.1016/j.neuroscience.2017.09.056 ↗
91. 10.1002/advs.20240042610.1002/advs.202400426 ↗
92. 10.1016/j.molcel.2020.09.00610.1016/j.molcel.2020.09.006 ↗
93. 10.1038/s41366-018-0031-310.1038/s41366-018-0031-3 ↗
94. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
95. 10.1073/pnas.050658010210.1073/pnas.0506580102 ↗
96. 10.1038/s41587-023-01767-y10.1038/s41587-023-01767-y ↗
97. 10.1016/j.cell.2021.04.04810.1016/j.cell.2021.04.048 ↗
98. H.Akaike inSecond International Symposium on Information TheoryBudapest 1973.
99. J.Bolt R.Inklaar H.deJong J. L.vanZanden 2018 174Groningen Growth and Development Center GGDC Research Memorandum.